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                                                            INTRODUCTION
Hypopharyngeal carcinoma is associated with the highest mortality of all cancers of the 
head and neck. Poor survival rates are attributed to a preponderance of late presentations 
and to the unique behaviour of tumors occurring in this location. Tumors of this region 
typically  remain  silent  until  the  disease  has  reached  an  advanced  stage  and  causes 
symptoms from airway or digestive tract obstruction or pain from neural invasion. These 
are usually aggressive in behaviour, grow in an area of abundant lymphatic drainage, fail to 
produce  early  symptoms  and  signs  and  usually  occur  in  people  who  are  depleted 
nutritionally and immunologically compromised and hence treatment is difficult. Squamous 
cell  carcinoma (SCC) accounts  for  95% of  hypopharyngeal  pathology.  It  is  one  of  the 
leading cause of cancer related morbidity and mortality in our country.  Incidence of head 
neck cancer in India according to National Cancer Registry (2004-2005) 16.4 per 100,000 
in males and in females 6.7 per 100,000 and hypopharyngeal cancer constitute 2.4 and 0.8 
per 100,000 males and females respectively. Incidence of head neck cancer according to 
Madras Metropolitan Tumor Registry (MMTR 2003 -2005) 22.1 and 9.3 per 100,000 males 
and females respectively and hypopharyngeal cancer incidence is 3.7 and 1.6 per 100,000 
males and females respectively and Hypopharyngeal cancer constitute 5.3% and 2% of all 
cancers  in  males  and  females  respectively  in  our  institute  and around  100  cases  of 
hypopharyngeal cancers are registered every year in our institute. More than 70% of these 
cases present with advanced stages III and IV. 
Hypopharyngeal  carcinoma  is  associated  with  a  high  incidence  of  submucosal  spread, 
which can be difficult to detect clinically and can result in underestimating the extent of 
disease. Cervical metastases are present in 60-80% of patients who have hypopharyngeal 
tumors have stage III or IV. They are less amenable to definite treatment by surgery and/or 
radiotherapy. Locoregional control with surgery or radiotherapy alone is extremely poor. 
The  overall  5-year  disease-specific  survival  rate  is  approximately  30%  to  35%1 using 
multimodality approach.  Despite  increasing use of  laryngeal  preserving protocols,  Total 
laryngopharyngoesophagectomy (TLPO) remains the gold standard treatment  for  locally 
advanced hypopharyngeal and upper oesophageal cancers. Nevertheless, recent advances in 
reconstructive techniques and perioperative care have allowed TLPO for advanced disease 
with single-stage reconstruction with gastric pull-up for a functional alimentary tract.  In 
addition, improved locoregional control has been demonstrated with the use of combined-
modality  therapy.  Overall  survival  rates  remain  poor  and  largely  unaffected,  however, 
because of a shift in the pattern of failure from local to distant disease and the development 
of second primary tumors. Therefore, treatment goals are aimed at eradicating disease and 
restoration of function, while causing the least morbidity and the most effective palliation of 
symptoms.  
Surgical ablation of advanced tumors of the hypopharyngeal and upper esophageal regions, 
together  with  optimal  reconstruction  of  the  resultant  defect,  has  remained  a  surgical 
challenge. The goal of this surgery is a single stage reconstruction with low morbidity and 
mortality, short hospital stay, and early restoration of swallowing.
ANATOMY OF HYPOPHARYNX:
The  hypopharynx,  or  laryngopharynx,  is  interposed  between  the  oropharynx  and  the 
esophagus.  It  extends  from  the  level  of  the  hyoid  bone  or  from  the  level  of  the 
pharyngoepiglottic  fold  down  to  the  upper  esophageal  sphincter  which  corresponds 
approximately to the sixth cervical vertebrae or the lower border of the cricoid cartilage. It 
is  bordered  anteriorly  by the  larynx and posteriorly  by the  retropharyngeal  space.  It  is 
subdivided  into  three  regions:  the  pyriform  sinuses,  the  post-cricoid  region,  and  the 
posterior pharyngeal wall.
The pyriform sinuses are pyramidal shaped areas with the base situated superiorly and the 
apex inferiorly. The superior extent is the oropharynx and pharyngoepiglotic folds. It  is 
divided into a superior or membranous part and inferior or cartilaginous part. The superior 
aspect of the pyriform sinus bounded laterally by the thyrohyoid membrane, through which 
passes  the  internal  branch  of  superior  laryngeal  nerve.  The  lower  portion  bounded 
anterolaterally by the medial surface of the thyroid cartilage and the anteromedially by the 
lateral surface of the cricoid/arytenoid cartilages. The sinuses are bounded posteriorly by 
the lateral and posterior pharyngeal walls. 
The post-cricoid area  is  the posterior  surface  of  the  arytenoid and cricoid cartilages.  It 
terminates inferiorly at the pharyngoesophageal junction and is intimately related to the 
apex of each pyriform sinus laterally. 
The posterior pharyngeal wall extends from a level of the hyoid bone to the level at the 
lower extent of the cricoid cartilage. It meets the posterior oropharyngeal wall superiorly 
and meets the posterior wall  of  the esophagus inferiorly.  It  is  related posteriorly to the 
retropharyngeal space. 
The  hypopharyngeal  wall  is  made  up  of  mucosa,  pharyngobasilar  fascia,  constrictor 
musculature, buccopharyngeal fascia (in a lumen to external direction). 
The  mucosa  is  stratified  squamous  epithelium.  The  pharyngobasilar  fascia  is  more 
developed in the nasopharynx and is less so as it approaches the hypophayrnx. External to 
the  pharyngobasilar  fascia  is  the  musculature  composed  of  the  middle  and  inferior 
constrictors. 
The constrictors are innervated by the laryngeal nerves as well as the pharyngeal plexus. 
The middle constrictor takes its origin from the lesser/greater cornu of the hyoid bone and 
the inferior constrictor originates from the oblique line of the thyroid cartilage as they both 
insert into the midline pharyngeal raphe. The lower fibers of the inferior constrictors blend 
into the cricopharyngeus muscle. 
The buccopharyngeal fascia is a thin layer covering the external aspect of the constrictor 
muscles. There are gaps between the constrictors as they overlap one another. 
The  glossopharyngeal  nerve,  styloid  ligament,  stylopharyngeus  muscle,  and  the  lingual 
artery  traverse  the  gap  between  the  superior  and  middle  constrictor  muscles.  The  area 
between  the  middle  and  inferior  constrictors  is  not  a  true  gap  since  the  thyrohyoid 
membrane closes this area. However, the superior laryngeal artery and vein, as well as the 
internal laryngeal nerve traverse this area. The inferior laryngeal artery and vein and the 
recurrent  laryngeal  nerve  traverse  the  space  between  the  inferior  constrictor  and  the 
esophagus.
LYMPHATIC DRAINAGE OF HYPOPHARYNX
Lymphatic drainage of the hypopharynx is extensive. The pyriform sinuses are drained by a 
network  of  lymphatics,  which  drain  primarily  to  the  upper  and  middle  jugular  nodes, 
posterior  cervical  nodes,  and retropharyngeal  lymph nodes.  Lymphatics  of  the posterior 
wall of the hypopharynx drain to the jugular nodes and retropharyngeal nodes. Postcricoid 
lymphatics  drain  to  the  middle  and  lower  jugular  nodes  and  to  the  paratracheal  nodes 
(Million, 1994). Between 60% and 75% of patients will have clinically involved neck nodes 
(node  positive)  at  presentation  and  more  than  one  third  of  patients  without  clinically 
evidence of nodal disease will harbour occult     metastases   3-8.  In patient with N+ disease, 
Level II (72%-75%), III(55%-72%), and IV (21%-45%) are most often affected; Level I 
(1%-10%) and V ( 11%-15%) are less commonly affected9,10.  Controlateral occult nodal 
metastases are present in 37% of patients with N+ disease11. In patient who has clinically 
N0 tumors,  36% harbour occult  nodal  metastases in the ipsilateral  neck, and 27% have 
occult disease in the contralateral neck  11. Metastatic disease involves the retropharyngeal 
lymph nodes in at least 20% of patients who have hypopharyngeal cancer12.  
SPREAD
The  intimate  association  between  the  hypopharynx  and  the  larynx,  oropharynx,  and 
esophagus provide for  certain  dissemination  routes  of  malignant  disease.  Cancer  of  the 
medial  wall  of  pyriform  sinus  may  spread  superficially  toward  the  lateral  epilarynx 
(aryepiglotic  fold,  arytenoids).  It  may  infiltrate  deeply  to  the  pharyngolaryngeal  wall, 
including the cricoarytenoid joint. Involvement of pre-epiglotic and paraglotic spaces and 
involvement of recurrent laryngeal nerve beneath the mucosa of pyriform sinus may lead to 
fixation of hemilarynx. Tumors of the lateral wall spread rapidly to the ala of the thyroid 
cartilage and thereafter the ipsilateral thyroid lobe. 
Cancer of the postcricoid region frequently invades the posterior cricoarytenoids muscles 
and the cricoid and arytenoids cartilges. The apex of the pyriform sinus terminates in the 
postcricoid  area  and  is  often  invades  early.  Advanced  tumor  may  totally  encircle  the 
hyphopharyngeal lumen.
Cancer of the posterior pharyngeal wall usually manifests as ulcerating and infiltrating 
lesions that spread both superficially and submucosally to the entire posterior pharyngeal  
wall from the nasopharynx to the cervical esophagus. These lesions may spread posteriorly 
to the prevertebral muscles and the retropharyngeal space, but vertebral bone extension is  
rare.  Carcinomas  of  posterior  pharyngeal  wall  may  spread  laterally  to  both  pyriform  
sinuses.
Distant metastases is rare at presentation mostly to lung, bones and liver commonly.
EPIDEMIOLOGY 
The incidence of hypopharyngeal cancer is much higher in men than in women, although 
the incidence in women is rising as more women are smoking. The annual incidence is 1 
per 100,000 persons and corresponds to 8% to 10% of head and neck malignancies. Highest 
incidence countries are France and India with an annual incidence ranging between 8 and 
15 per100,000 men.25. These cancers usually occur during the second half of life, with a 
peak incidence in fifth and sixth decades. The increase incidence of hypopharyngeal cancer 
is closely associated with lower socioeconomic classes and lower level of education.    
1. More common in Western India and Far East. But all races are affected (David Wight 
1970) often seen in fifth and sixth decade.
2. Males are commonly affected because of habits of smoking, pan and tobacco chewing 
but rare in females (J D baruah 1980, SC Pandi 1974 John A Keichner 1975)
PRE DISPOSING FACTORS:
Tobacco and ethanol are the principle carcinogens responsible. Long-term exposure causes 
progressive cellular dysregulation by alteration of tumor suppressor genes such as  TP53, 
amplification of proto-oncogenes such as cyclin D1, and damage to regulatory factors such 
as transforming growth factor–beta (TGFβ)  and retinoic acid receptors. The progression 
from  normal  mucosa  to  cancer  correlates  with  accumulation  of  genetic  abnormalities. 
Genetic factors are under investigation. Heritable polymorphisms of expression of enzymes 
that  activate  tobacco-related  procarcinogens  (eg,  aryl  hydrocarbon  hydroxylase)  and 
detoxify  carcinogens  (eg,  glutathione  S-transferase)  have  been  identified.  Certain 
polymorphisms  in  the  alcohol  dehydrogenase  genes  may  increase  the  risk  of  oral  and 
pharyngeal cancers related to alcohol consumption. Racial differences in the metabolism of 
carcinogens may be a possible cause of the increasing incidence in African Americans. 
Deficient DNA repair mechanisms increase susceptibility to head, neck, and other cancers. 
Clinically  recognized  syndromes  include  xeroderma  pigmentosum,  Bloom  syndrome, 
ataxia-telangiectasia, and Fanconi anemia.
 Irritation:  Hypopharynge cancer is definitely linked to the excessive use of
 both tobacco and alcohol, which are generally the prime etiologic factors for squamous cell 
carcinoma of the upper aerodigestive tract. Long standing irritation due to smoking, tobacco 
chewing,  alcoholism  and  nutritional  deficiencies  leads  to  hyperkeratosis,  dyskeratosis, 
leokoplakia and finally malignancy.
The Plummer-Vinson or Paterson-Brown Kelly syndrome represents a
 combination  of  dysphagia,  postcricoid  web,  weight  loss,  and  iron  deficiency anaemia, 
usually occurring in non-smoking women between the ages of 30 and 50 years. Patients 
with this syndrome are at higher risk of developing cancer of the hypopharynx, particularly 
in postcricoid region. 
The  role  of  human  papilloma  virus  (HPV)  in  cancers  of  the  hypopharynx  is  unclear, 
although  it  may  play  more  of  a  role  in  cancers  of  the  oropharynx  and  oral  cavity. 
Epidemiologic and molecular biology studies have suggested that HPV infection may be 
associated with cancers of the head and neck. Based upon the most sensitive method of 
detection, polymerase chain reaction (PCR), the overall prevalence of HPV in head and 
neck tumors was 20% to 34.5% (416 of 1205 tumors) [90,91]. Among head and neck sites, 
HPV was most often detected in tumors of the oral cavity (59%), followed by the pharynx 
(43%), and larynx (33%). 
CLINICAL FEATURES
Sore throat, sensation of foreign body and then mucus retention that felt only on swallowing 
are the commonest symptoms. More than 50%-70% patients present with clinically obvious 
cervical nodes and in half of these the neck mass is the presenting symptoms. Voice change 
is a late symptom and usually due to impairment of vocal cord function by invasion into 
endolarynx  or  of  recurrent  laryngeal  nerve.  Weight  loss,  because  patient  has  lost  their 
ability to swallow comfortable or have lack of willingness to swallow because of fear of 
aspiration.  Dysphagia  due  to  tumor  invasion  often  causes  a  combination  of  painful 
swallowing (odynophagia) and neuromuscular dysfunction (dysphagia) and most commonly 
large circumferential tumour which completely occlude the lumen. Otalgia, referred pain to 
the ear is mediated by branches of the tenth cranial nerve. Invasion of the laryngeal nerve 
causes spread of neuropathic impulses to the auricular nerve (Arnold’s nerve, sensory to 
posterior  external  auditory  canal  and  back  of  pinna).  Fetid  breath,  halitosis  is   due  to 
saprophytic bacterial overgrowth in fungating necrotic tumors.
PHYSICAL EXAMINATION
Performance status to assess the general health condition whether he/she will withstand a 
particular treatment procedure. Most of the patient of hypopharyngeal cancer patient will be 
nutritionally  poor  and they  may require  nutritional  support  before  definitive  procedure. 
Neck examination which includes examination and documentation the size, location, and 
number of palpable lymph nodes in all  cervical  and supraclavicular node-bearing areas. 
Documentation  of  laryngeal  expansion  if  present.  Assessment  thyro-vertebral  crackle. 
Tenderness suggests invasion of prevertebral muscles excludes curative treatment options, 
while loss of normal thyrovertebral crepitus suggests invasion of prevertebral tissue or a 
large  postcricoid  tumor.  Assessment  of  extrapharyngeal  extension  of  disease  and 
involvement of thyroid gland. Examination of oral cavity under good light to exclude other 
regional pathologies, including the synchronous oral cavity or oropharyngeal tumors, might 
be seen.  Lesion extending to posterior pharyngeal wall of oropharynx can be seen directly. 
The Indirect laryngoscopic examination to know the site and extension of disease, but it 
cannot reveal lower pyriform sinus or postcricoid lesions. Fiberoptic laryngoscopy is the 
examination  of  choice.  Findings  include  mass  lesions,  hyperkeratotic  or  erythematous 
mucosal lesions, ulcerations, and vocal cord paralysis. General examination and systemic 
examination to exclude distant metastases and for comorbidities as patient has to withstand 
major surgical procedure.
LAB STUDIES
- Routine Hematological examination and Blood Biochemistry
- Prothrombin time (PT) and activated partial thromboplastin time (aPTT): These are used 
to assess the safety surgical procedures. 
IMAGING STUDIES
- Chest x-ray films to check for lung metastases, synchronous lung cancer, and comorbid 
heart or lung disease. 
- CT scan Head and neck - Evaluate local extent of tumor and cervical nodes, and very 
rarely MRI of head and neck to assess the extension of disease. Other Tests as required by 
anaesthetist for assessment for fitness for major surgery
PROCEDURES
- Biopsy - To confirm diagnosis and usually is performed during a Flexible fiberoptic Direct 
laryngoscopy and Direct pharyngoscopy (DLDP) & UGI endoscopy.
DLDP & UGI endoscopy.
This operating room procedure, performed by a surgeon, is an essential step in planning the 
definitive treatment for all  head and neck subsites.  With rigid direct  larygoscopy under 
general anaesthesia the extent of the tumor can most accurately be ascertained & mostly 
when there is doubt about the extension of disease in fiberoptic flexible endoscopy. Post 
cricoid region and involvement of pyriform sinus can be accurately assessed in rigid DL. 
Biopsies  of  all  suspicious  lesions  are  taken.  Esophagoscopy  are  performed  to  rule  out 
synchronous cancers and for assessment of stomach tube if scope can be introduced beyond 
the lesion. 
HISTOPATHOLOGY IN HYPOPHARYNGEAL CANCER
More than 95% of hypopharyngeal tumors are squamous cell carcinoma, less than 60% are 
keratinizing, 33% are nonkeratinizing, and all  are usually poorly differentiated. Variants 
include basaloid squamous cell carcinoma, superficial spreading cancer, sebaceous cancer, 
adenosquamous cancer, and signet-ring and verrucous types. Uncommon histologic types 
include adenocarcinoma, lymphoma, and sarcoma.
Studies have reported that tumor margins are usually infiltrating (80%) but can be pushing 
(20%). Skip lesions or multifocal areas of disease are not unusual. Histologic factors that 
denote a higher risk tumor include lymphovascular invasion, perineural invasion, or poorly 
differentiated cell morphology.
Natural history of hypopharyngeal squamous cell carcinomas
In general, 30% of patients have local disease at the time of diagnosis, 60-70% have local 
regional  disease,  and 6% present  with distant  metastases  37.  In  the  United  States,  most 
hypopharyngeal  tumors  (60-70%)  arise  in  the  pyriform  sinus,  25%  are  found  in  the 
posterior pharyngeal wall, and 5% are found in the posterior cricoid region. Most patients 
present with large T3 or T4 tumors. Medial wall pyriform sinus tumors usually spread along 
the mucosal surface to the aryepiglottic folds and can invade into the larynx by involving 
the paraglottic space. Tumors of the lateral wall and apex commonly invade the thyroid 
cartilage. Once the tumor penetrates the constrictor muscle, it can spread along the fascial 
planes to the base of skull. 
Because of the abundant lymphatics in the region and the extent of the primary tumor at 
diagnosis, metastasis to the regional lymph nodes is common.
The location of the lymph node metastasis is an important consideration in the treatment of 
hypopharyngeal cancers. In necks that are clinically negative, the lymphatic drainage is to 
the cervical nodal groups, with level II and III nodal regions typically involved. In necks 
that  are  clinically  positive,  not  only  is  the  risk  of  occult  contralateral  neck  metastasis 
increased, but the risk of involvement of level I and V must also be considered because the 
risk is approximately 10% for these sites. This is likely due to an alteration in the lymphatic 
flow pattern found in clinically involved nodes, typically in the level II and III regions of 
the anterior cervical neck. The increased risk of retropharyngeal lymph node metastasis in 
patients with cervical lymph node metastasis is more significant (as high as 90%) when 
compared with patients without cervical lymph node metastasis.
This altered lymphatic spread pattern is also influenced by the location of the cancer within 
the hypopharynx. For cancers that involve the pharyngeal wall, as opposed to the pyriform 
sinus, the risk of level I and V nodal metastasis appears to be as high as 20%.
Patients with cancers of the hypopharynx, particularly cancers that involve the postcricoid 
region (with or without extension into the cervical esophagus) are also at an increased risk 
of paratracheal lymph node metastasis. This risk may be as high as 35% and increases in the 
presence of cervical nodal metastasis. Treatment for these cancers should be considered in 
patients with mucosal involvement of the postcricoid region, with or without extension into 
the cervical esophagus.
Eight to 26% of patients present with a second primary tumor that is either synchronous 
(current) or metachronous (sequential). The secondary malignancies usually occur in the 
oropharynx,  lung,  and  esophagus.  Synchronous  primary  tumors  are  rare  (7.4%). 
Metachronous  lesions are  more  common and can occur at  a  rate  of  2  to  4% per  year. 
Overall, some series report second primary tumors as a cause of death in 16% of patients.
GENERAL PRINCIPLES OF TREATMENT
Currently,  several  treatment options exist for patients who have hypopharyngeal cancer. 
Surgery combind with radiation therapy is the standard treatment for most patients who 
have hypopharyngeal carcinoma. Radiation therapy alone also may be used and seems to be 
most  useful  for  small  (T1 or  T2)  lesions.  Hyperfractionated  radiation therapy seems to 
confer  some  advantages  over  conventional  radiation  therapy  in  improved  locoregional 
control. Organ preservation therapy using chemoradiation is being increasingly studied and 
may  result  in  larynx  preservation  in  one  third  of  patients.  Cetuximab,  a  monoclonal 
antibody against the epidermal growth factor receptor, plus radiotherapy for locoregionally 
advanced squamous-cell carcinoma of the head and neck has emerging but the use of this 
antibody did not improve the survival among patients with hypopharyngeal cancer 14.
SURGICAL TREATMENT
Preoperative  evaluation  is  critical  including  age  and general  condition  and presence  of 
intercurrent of illness of the patient in determining the appropriate surgical approach for 
treatment of hypopharyngeal carcinoma. The location and extent of disease determine the 
extent of resection required. Accurate staging is necessary to assess the defect whether a 
partial or circumferential hypopharyngeal defect after resection and total laryngectomy is 
required or not and to know the extent of neck dissection. 
The predilection of hypopharyngeal carcinoma for submucosal spread must be kept in mind 
when planning resection of the primary tumor. Wei15 suggested that based on measurement 
of submucosal extension in whole organ studies, an adequate resection margin in patients 
who have not received previous radiation therapy is 15mm superiorly, 30mm inferiorly, and 
20mm laterally. Patients who have undergone previous radiation therapy require resection 
margin of 20mm superiorly, 40mm inferiorly, and 30mm laterally. The deeper margin in 
either  situation  should  be  greater  than  1mm to  ensure  complete  removal  of  the  tumor 
without leaving residual disease in the prevertebral musculature 15. 
TOTAL LARYNGOPHARYNGOESOPHAGECTOMY (TLPO)
TPLO is indicated in the following instances16:-
1. Annular postcricoid carcinoma
2. Extensive lesions of the pyriform sinuses with involvement of more than two thirds of 
the circumference of the hypopharynx.
3. Extensive posterior pharyngeal wall lesions with involvement of the larynx
4. Carcinoma of the cervical esophagus.
5. Carcinoma of hypopharynx that involves the apex of the pyriform sinus. The proximity 
of  the  apex of  the  pyriform to the  postcricoid  mucosa  requires  total  laryngectomy and 
cervical esophagectomy in addition to partial pharyngectomy for removal of the tumor and 
results in a circumferential pharyngeal defect 3.
REVIEW OF LITERATURE
Currently,  several  treatment options exist for patients who have hypopharyngeal cancer. 
Surgery combined with radiation therapy is the standard treatment for most patients who 
have hypopharyngeal carcinoma.
PRIMARY RADIATION THERAPY 
The  results  of  treatment  with  primary  radiation  therapy  for  curing  patients  who  have 
hypopharyngeal cancer are not so favourable. Local control rates early-stage disease have 
been reported to range from 77% to 89%, with 5 year disease-specific survival rates as high 
as 69%  [3,  37,  59].  Advanced-stage primary disease (T3 and T4) and advanced-stage nodal 
disease (N2 and N3) are associated with dismal rates of laryngeal preservation and 5 year 
disease-specific  survival  rates  of  0  to  12%.  Surgical  salvage  after  failure  of  radiation 
therapy is successful in less than 10% of patients, and larynx preservation is rarely possible 
[60, 61].  Fewer than one third of patients are alive at 5 years with a functional larynx62. 
Several nonrandomized studies reported that hyperfractionated radiation therapy provides a 
15% to 25% improvement in local control rates for larger tumors.89.  There is an increased 
incidence of treatment-related complications in hyperfractionated radiation therapy when 
compared  to  conventional  radiotherapy  and  these  complications  are  dose  related. 
Hyperfrationated  radiation  therapy  seems  to  improve  local  control  rates  but  incurs 
socioeconomic and time constraints and does not seem to result in improved survival when 
compared to conventional radiation therapy. 89 
CHEMOTHERAPY
For a long-time chemotherapy was used primarily for palliative purpose only because of 
poor activity in Head and Neck cancer. A new era in the management of cancer of Head and 
Neck  was  initiated  in  the  early  1980s  with  the  introduction  of  platinum-based 
chemotherapeutic regimens.  Clinical studies using cisplatin as a single agent or more often 
in combination with other drugs have demonstrated partial response rates of 40 to 50%, and 
complete response rates of 20% to 30%, for an overall response rate ranging between 78% 
and 94%. 65,  66.   In the early 1990s, it appeared obvious that use of chemotherapy had not 
provided any improvement in survival benefit for most patients. The major meta-analysis 
carried out at the Institut Gustave Roussy (Meta-analysis of Chemotherapy in Head and 
Neck  Cancer  [MACH-NC]67 which  included  more  than  10,000  patients  enrolled  in 
randomized  trials  comparing  conventional  treatment  with  the  same treatment  combined 
with chemotherapy ( adjuvant or induction or concomitant). The conclusion of this meta-
analysis  was  that  adjuvant  chemotherapy,  as  well  as  induction  chemotherapy  (4%), 
produced  a  nonsignificant  increase  in  survival  (1%).  Concomitant  chemoradiotherapy 
resulted  in  a  significant  increase  in  survival  of  8%,  but  this  group  had  a  mixture  of 
definitive and postoperative radiation trials.     
CHEMORADIOTHERAPY
Patients who respond to chemotherapy show a subsequent response to definitive radiation 
therapy, suggesting that tumors that are sensitive to chemotherapy are radiosensitive. In 
1990, the use of chemoradiation for organ preservation was established by Department of 
veterans Affairs Laryngeal Cancer Study Group in a landmark prospective randomized trial 
63.  Induction  chemotherapy  with  cisplatin  and  5-FU,  followed  by  definitive  full-course 
radiation therapy in responders, resulted in larynx preservation two thirds of patients who 
otherwise would have required total laryngectomy, without compromising survival.
The only randomized,  prospective  phase  3  trial  to  date  investigating  chemoradiation  in 
patients who have hypopharyngeal cancer was conducted by the EORTC Head and Neck 
Cancer  Cooperative  Group  64.   Patients  with  T2  to  T4  lesions  who  required  total 
laryngectomy as part  of definitive surgical  treatment were randomized to receive either 
induction chemotherapy with cisplatin and 5-FU followed by definitive radiation therapy, or 
to surgery with postoperative radiation therapy. This trial found no significant difference 
between the chemoradiation arm and surgery arm in local (12% and 17%, respectively) or 
regional  (19%  and  23%)  recurrences  rates  and  5  year  disease  free  survival  rates.  A 
decreased incidence of distant metastases was identified in the organ preservation group 
compared with the surgery group (25% versus 36%, respectively). The 5 year estimate of 
retaining a larynx for the chemoradiation group was 35%.  
SEQUENTIAL THERAPY
Patient treated with induction chemotherapy continue to have a high rate of locoregional 
treatment failure,  whereas chemoradiotherapy has reduced locoregional  treatment failure 
with no improvement in control in distant disease. This has lead to the development of 
sequential therapy approaches, combining induction chemotherapy, chemoradiotherapy and 
surgery.  Recent  phase  III  data  have shown that  adding a  taxane to  cisplatin  and 5-FU 
induction chemotherapy results in a significant improvement in survival with less toxicity. 
Phase III Study by Hitt et al67   induction taxane with cisplatin and 5-FU(TPF) have followed 
by cisplatin based chemoradiotherapy(CTRT) versus induction with cisplatin and 5-FU (PF) 
followed by cisplatin based CTRT in resectable and unresectable Head and Neck cancer 
patients  have shown improvement in response and in overall survival in patient treated with 
TPF. Complete response rate was 33 % and 14 % for TPF and PF respectively. Toxicity 
with TPF arm was less than that of PF arm. Second phase III trial by Vermorken et al.68 
patients with unresectable disease were treated with Docetaxel-based cisplatin and 5-FU 
(TPF)  or  cisplatin  and  5-FU,  followed  by  radiotherapy.  Survival  in  TPF  arm  was 
significantly superior to that obtained in cisplatin and 5-FU arm and toxicity was better with 
TPF  compared  to  cisplatin  and  5-FU  68.      Although  sequential  therapy  makes  sound 
biological sense and seems to be highly effective, it still remains experimental.
MONOCLONAL ANTIBODY IN HYPOPHARYNGEAL CANCER :
The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor 
tyrosine  kinases,  is  abnormally activated  in  epithelial  cancers,  including head and neck 
cancer.69, 70.. The cells of almost all such neoplasm express high levels of EGFR, a feature 
associated  with  a  poor  clinical  outcome.[69,  71-76] . Radiation  increases  the  expression  of 
EGFR in cancer cells, and blockade of EGFR signaling sensitizes cells to the effects of 
radiation.[77,78] 
Cetuximab,  an IgG1 monoclonal  antibody against  the ligand binding domain of  EGFR, 
enhances the cytotoxic effects of radiation in squamous-cell carcinoma [79-83]. Cetuximab as 
a single agent or combined with cisplatin was also associated with clinically significant 
rates of tumor regression in patients with platinum-refractory head and neck cancer.[85,  86] 
Bonner et al.87 report on the phase 3 study of cetuximab, a monoclonal antibody against the 
epidermal growth factor receptor, plus radiotherapy for locoregionally advanced squamous-
cell carcinoma of the head and neck.  Bonner et al. found an improvement in locoregional 
control,  progression-free  survival,  and  overall  survival  among  patients  treated  with 
cetuximab  plus  radiotherapy,  as  compared  with  radiotherapy  alone.  Furthermore,  the 
addition of cetuximab did not increase the incidence of severe mucositis. However, Bonner 
et al.  did not compare the combination of cetuximab plus radiotherapy with the current 
standard of  care  — platinum-based chemoradiotherapy and they did not  administer  the 
radiotherapy uniformly among all patients.  These caveats complicate the interpretation of 
the  study’s  results. In  this  cetuximab  appeared  to  be  effective  only  when  added  to 
hyperfractionated radiotherapy. In subset analysis there was no benefit in hypopharyngeal 
cancer. The  long-term,  absolute  improvement  has  yet  to  be  determined,  however,  and 
adding cetuximab had no effect on distant metastases. Moreover, the benefit from adding 
cetuximab to radiotherapy may be specific to particular sites of head and neck cancer and to 
the type of radiotherapy that is administered. Whether cetuximab plus radiotherapy is a 
better  therapy  than  platinum-  based  chemoradiotherapy  and  whether  cetuximab  can  be 
added to platinum-based chemoradiotherapy are important questions, the answers to which 
require randomized phase 3 studies.  These are already under way.
Treatment  of  advanced  carcinoma  of  the  head  and  neck  regions  remain  a  challenging 
problem to  the  oncologists  world  wide.   Despite  advances  in  surgical  and  nonsurgical 
treatment, overall survival rates for patients who have hypopharyngeal carcinoma have not 
improved, and the disease still has a poor prognosis. The best results are obtained with 
multimodality therapy, but at best, two thirds of patients are palliated rather than cured of 
disease.  For  most  patients,  surgery  alone  does  not  provide  sufficient  disease  control. 
Retrospective reviews comparing surgical treatment alone with surgery plus postoperative 
radiotherapy have shown decreased locoregional recurrence rates (11%-14% Vs 39%-57%, 
respectively) and improved 5 year disease-specific survival rates ( 40%-48% Vs 18-25%, 
respectively) with the addition of postoperative radiation therapy(8,13). Radical surgery with 
postoperative radiation therapy remains the standard of care. Organ preservation strategies 
have not been as successful in hypopharyngeal cancer as for cancers of other head and neck 
sites. Chemoradiation is an effective alternative method of aggressive treatment but may be 
associated with significant dysfunction of end organ when preservation is possible. Because 
of poor long-term survival rates, local control remains the most important factor in planning 
treatment, to provide meaningful palliation and best possible quality of life.
 A recapitulation of the experience of the past 50yrs with TLPO with pharyngoesophageal 
reconstruction  demonstrates  numerous  instances  of  prolonged  hospitalisation,  multiple 
operations, and persistent salivary fistulae. Effective palliation however, is possible only if 
reconstruction  of  the  pharyngoesophageal  segment  is  accomplished  rapidly  and 
consistently. Unfortunately, this is not an easy task. All too often the tumor recurred before 
reconstruction of the esophagus completed.
With Pharyngoesophageal reconstruction, as with all difficult surgical problems when no 
single approach has offered an ideal solution, a large number of different techniques, with 
their  inherent  difficulties,  have been supplanted by new procedures  that  have produced 
more consistently successful results with greater rapidly and with less morbidity than was 
previously feasible. The advent of free tissue transfer procedures and one-stage procedures 
involving  transfer  of  abdominal  viscera  has  revolutionized  the  reconstruction  of  the 
hypopharynx and the cervical esophagus.  Several feasible options are now available for 
reconstruction of these massive defects, all of which have good success when performed 
properly.
Historically,  various  methods  of  reconstruction  have  been  used  after  resection  of  the 
pharynx,  hypopharynx,  and  cervical  esophagus.  These  have  included  local  skin  flaps; 
deltopectoral flaps; reversed gastric tube esophagoplasty; pectoralis major myocutaneous 
flaps; visceral interposition with stomach or colon; and free tissue autografts utilizing colon, 
jejunum,  and tubed radial  forearm flaps.  Free  jejunal  transfer  has  become the  standard 
technique for  reconstruction of  the pharynx and hypopharynx,  especially  with proximal 
lesions [3-5] whereas gastric tube interposition is the technique of choice for reconstruction of 
the hypopharynx and cervical  esophagus when the resection extends below the thoracic 
inlet [6-11].
The first successful resection of the cervical esophagus was performed in 1877 by Czerny. 
Mikulicz reported the first successful cervical esophagus reconstruction in 1886.  A variety 
of pharyngoesophageal reconstructive techniques have emerged between 1900 and 1995. 
The Cervical flaps are amongst the earliest methods of reconstruction.  Wookey popularized 
the  repair  of  pharyngoesophageal  defects  using  local  cervical  tissues  in  1942.  He used 
laterally based cervical flaps which were partially folded back on themselves and sutured is 
the pharyngeal and esophageal ends to form a tube that was open laterally.  The tubing of 
the flap was completed later and the neck defect was covered with a spilt thickness skin 
graft.  Many modifications of this technique have been described, but the basic principle of 
using anterior cervical skin to resurface the neopharynx is constant.  The modifications deal 
with  different  strategies  for  the  resurfacing  the  neck  defect.  The  use  of  skin  form the 
anterior chest wall for reconstruction of the pharyngoesohagus regained popularity in the 
1960's with description of the deltopectoral flap by Bakamjian.  This remained the standard 
method of reconstruction until the advent of the myocutaneous flap in the late 1970's.
The  use  of  the  pectoralis  major  myocutaneous  flaps  (PMMC)  in  head  and  neck 
reconstruction was first described by Aryian in 1979. Theogaraj in 1980 reported a series of 
pharyngoesophageal reconstruction using a tubed PMMCF. A variety of abdominal viscera 
have been used to reconstruct the alimentary tract after resection of the hypopharynx and 
cervical  esophagus.   Ong  and  Lee  in  1960  reported  a  technique  of  mobilizing  and 
anastomosing  the  stomach  to  the  pharynx.   Keling  and  Vuillet  were  the  first  to 
independently report on a transverse colon transposition for reconstruction of the esophagus 
in  1911.   Huguier  et  al  in  1970  reported  the  first  series  of  free  jejunal  grafts  for 
reconstruction of the cervical esophagus.  Many modifications have been described in an 
effort to decrease mortality and morbidity but the basic techniques remain the same. The 
use of tubed radial forearm free flap was first reported by Harii in 1985.  Reports of the use 
of  other  fasciocutaneous  free  flaps  for  reconstruction  of  the  cervical  esophagus  and 
hypopharynx have surfaced since then.
GASTRIC TRANSPOSITION:
Replacement of the esophagus by transposition of the stomach tube through the posterior 
mediastinum into the neck with direct  pharyngogastric  anastomosis  has  proved to  be a 
satisfactory procedure in selected cases. Resection of the pharynx and larynx is combined 
with closed resection of the thoracic esophagus. The stomach tube is transposed through the 
posterior mediastinum, in the bed of the previously resected esophagus. The operation is 
performed in one stage, and only one anastomosis is required.  The blood supply of the 
transposed stomach superior to that of other organs used as esophageal substitutes, and the 
pharyngogastric anastomosis is particularly resistant to stricture formation or leakage.   
The idea of performing blunt total esophagectomy through cervical and abdominal incision 
was  suggested  by  Denk17 who  in  1913  performed  the  procedure  in  cadavers  and 
experimental animals. Turner18, in 1936, was the first to use this approach successfully for 
resection of intrathoracic esophageal  carcinoma. In 1960 Ongo and Lee19 reported three 
cases  of  transposition  of  the  stomach  through  posterior  mediastinum  for  esophageal 
replacement after pharyngolaryngectomy. LeQuesne and Ranger20, in 1966, reported their 
experience with 14 cases of gastric transposition for esophageal replacement. The first three 
patients had undergone a three-incision procedure with laparotomy and thoracotomy,  as 
well as cervical dissection. Because of poor results obtained with these patients, the authors 
began  to  use  the  technique  of  closed  chest  blunt  dissection  of  the  normal  thoracic 
esophagus.  Elimination  of  the  thoracotomy lessened the morbidity  and mortality of  the 
procedure a great improvement in the results. Further modifications and improvements in 
the procedure were subsequently reported by Stell21,  Leonard and Maran22,  Silver  23, and 
Akiyama et al 24.  
Gastric transposition is less suitable for hypopharyngeal tumors that extend upward rather 
than inferiorly. This is most often encountered with posterior pharyngeal wall lesions that 
rarely  extend  below  the  cricopharyngeal  muscle  but  may  extend  upward  into  the 
nasopharynx. Although transposed stomach easily reaches to the level of the base of the 
tongue,  posterior  pharyngeal  wall  anastomosis  farther  superiorly  would  be  difficult. 
Microvascula free flap is suitable in this situation.  Gastric transposition is quite successful 
in heavily irradiated patients (25, 26) and is preferred in these instances. 
Occasionally, gastric transposition is technically impossible. A gastroduodenal ulcer or a 
tumor or scarring and tissue loss from previous gastric surgery may preclude the use of the 
stomach  for  esophageal  replacement.  The  right  gastric  vessels  and  right  gastroepiploic 
vessels must be intact, and there should be no interruption of the vascular arcades along the 
greater curvature to ensure an adequate blood supply of the transposed stomach. Previous 
thoracic, mediastinal, or upper abdominal surgery may make blunt esophagectomy without 
thoracotomy impossible.
 RECONSTRUCTION CRITERIA
Reconstruction  of  a  defect  after  resection  of  the  hypopharynx  and  cervical  esophagus 
remains  one  of  the  greatest  challenges  to  the  head  and  neck  surgeon.   The  ideal 
reconstruction  would  restore  normal  anatomy,  allow  for  normal  deglutition  without 
aspiration, allow for development of speech and for breathing without a tracheotomy.  It is 
obvious that with our present skill and technology this type of reconstruction cannot be 
achieved.  Patients with advanced cancer of hypopharynx and cervical esophagus have a 
very poor prognosis. Survival of these patients is approx. 50% at 1 year 20-30% at 5 years. 
Consequently, surgery for these patients should be considered primarily palliative, and the 
optimal reconstruction should preserve the quality of life for the duration of survival. 
The optimal reconstruction should therefore have the following characteristic:  
• Single stage reconstruction.
• Low mortality & morbidity.
• Short hospitalization.
• Short interval to successful oral alimentation
• High rate of speech development.
• Tolerate postoperative radiation. (~ 6000cGy)
RECONSTRUCTIVE OPTIONS 
1) Local tissues
  a) Primary closure                      b)        Laryngeal flaps
2) Skin grafts
3) Cutaneous flaps
  a) Cervical                           b) Deltopectoral
4) Myocutaneous flaps
  a) Pectoralis major               b) Latissimus dorsi
  c)         Trapezius
5) Visceral transposition
  a) Gastric "pull-up"               b) Jejunal autograft (free flaps), 
  c) Colonic pullup.
6) Fasciocutaneous free flaps (FCF)
  a) Radial forearm                  b) Lateral thigh
  c) Scapula                              d)    Other
There  is  significant  increase  in  mortality  and  serious  morbidity  in  patients  undergoing 
visceral transposition.  The skin, myocutaneous, and free fasciocutaneous flaps patients had 
less mortality and morbidity, but a higher rate of stenosis and fistula formation. Single stage 
reconstructions are characterized by rapid alimentation (7-12 days).  The myocutaneus flap 
patients had a longer interval to alimentation (20-60 days) due to the high rate of significant 
fistulae which at times required a second procedure. 
Skin and muscle flaps tolerate radiation best, while the stomach tolerates it the poorest. The 
development  of  adequate  speech  with  the  aid  of  prosthesis  after  reconstruction  is  best 
achieved  with  the  FCF  followed  by  the  cutaneous  and  myocutaneous  flaps.   The 
development of speech with the visceral transpositions is generally poor but is better with 
the gastric pull-up. 
DEFECT FACTORS
The important defect factors are
1) Size:    the size of the defect can be classified as follows:
  a) Minor:   defect less than 30% of the circumference of the pharynx or
     resection of maximum of 2 cm of the pharyngeal wall
  b) Major:   defect that is greater than 30% but less than 70% of the
     pharyngeal circumference or a resection that is greater than 
     2 cm but at least a 2 cm stripe of pharyngeal mucosa is left
  c) Circumferential:   defect greater than 70% of the pharyngeal
     circumference or a resection were less than a 2 cm stripe of mucosa
     is left.
2) Presence of the larynx:  This can rarely be performed due to
   oncologic or functional reasons
3) Inferior extent of the tumor
Pradhan  SA et.  al.  analyzed  their  experience  of  Gastric  pull-up  for  cancers  of  the 
hypopharynx  and  cervical  esophagus.  Twenty-five  cases  of  squamous  cancer  of  the 
hypopharynx  and  cervical  esophagus  treated  with  laryngopharyngoesophagectomy  and 
pharyngogastric anastomosis were presented. Twelve patients had received full radiation 
therapy and surgery was undertaken for residual and recurrent disease. Eleven patients had 
a concurrent unilateral radical neck dissection and two patients a concurrent bilateral neck 
dissection. Five patients died within 1 month following surgery. The most notable features 
of this method of pharyngeal and cervical esophageal reconstruction is the early restoration 
of swallowing (20 patients were on oral feed in less than 10 days following surgery), a very 
low incidence of anastomatic leak and subsequent hazards of a carotid hemorrhage (only 
one patient had a major leak leading to carotid hemorrhage), and absence of subsequent 
anastomotic stenosis as is seen after reconstruction with skin tubes.
ISELI27 et  al  published  their  functional  outcomes  results  following  Total 
paryngolaryngectomy.  They  have  analyzed  18  patient  undergoing  total 
laryngopharyngectomy between July 2001 and July 2006 were prospectively recorded in a 
head and neck database. Out of eighteen patients who underwent laryngopharyngectomies 
with 5 having failed chemoradiotherapy and 13 presented with locally advanced tumours. 
Patients were reconstructed using free jejunal interposition if the lower anastomosis was in 
the neck (50%). They developed early fistulas (33%), late strictures (33%) and 44% spoke 
with  a  tracheo-oesophageal  puncture,  the  rest  with  an  electrolarynx.  If  the  lower 
anastomosis was below the manubrium, patients required a gastric pull-up (38.9%). Gastric 
pull-up patients had fewer fistulas but more number of chest complications. More gastric 
pull-up patients tolerated solid diet and 43% managed oesophageal speech, the remainder 
using an electrolarynx. Overall, 88.9% of jejunums and 100% of gastric pull-ups tolerated 
oral alimentation and 100% used verbal communication. During a mean follow up of 34 
months,  7  patients  (38.9%)  died;  four  patients  died  of  local  recurrence,  two  of  distant 
metastases and one of unrelated causes. They concluded surgical treatment of neoplasms of 
the hypopharynx and cervical oesophagus is technically demanding and involves careful 
postoperative  care  to  manage  complications.  Despite  having  a  poor  tumour-related 
prognosis, laryngopharyngectomy may be carried out in selected patients with low mortality 
and acceptable functional and survival results.
D.  F.  Harrison  28 et.  al between  the  years  1965  to  1977,  58  patients  with  advanced 
hypopharyngeal squamous carcinoma were treated by pharyngolaryngoesophagectomy and 
total thyroidectomy.  Operative  mortality  for  potentially  curable  cases  was  8.6%, with a 
crude three-year survival rate of 29% for all cases. Mortality was 37% for patients with 
postcricoid  tumors.  Long-term  management  was uncomplicated  except  for  calcium 
metabolism;  two patients  died  from nephrocalcinosis  secondary  to  return  of  circulating 
parathyroid hormone. 
Krespi  YP29 et.  al.  published  their  study  on  hypoparathyroidism  following  total 
laryngopharyngectomy and gastric pull-up .They were using the gastric pull-up technique 
for  closure  of  large  pharyngoesophageal  defects  after  radical  oncological  surgery  since 
1979. The management of severe hypocalcemia and hypovitaminosis D they seemed more 
difficult in patients undergoing pull-up reconstruction than in patients undergoing the same 
extirpative  surgery,  but  reconstructed  with  more  traditional  methods.  To  determine  if 
hypocalcemia and hypovitaminosis D were more common in gastric pull-up patients, and if 
postoperative  management  of  these  conditions  is  more  problematic  in  this  group,  they 
retrospectively compared three groups of head and neck surgery patients. Group 1 consisted 
of 17 patients undergoing total laryngectomy with thyroid complex preservation. Group 2 
consisted  of  7  patients  undergoing  mediastinal  dissection  with  total  laryngectomy-
thyroidectomy previously or  concurrently.  Group 3 consisted of  30 patients  undergoing 
total  laryngopharyngoesophagectomy-thyroidectomy  and  gastric  pull-up  reconstruction. 
The incidences of hypocalcemia requiring therapy were 12%, 50%, and 73%, respectively, 
with  an  overall  incidence  of  51%.  The  average  amounts  of  supplemental  calcium and 
vitamin D in the three groups were compared. A significant between the three groups was 
noted.  They conclude that  any patient  should  be  carefully  monitored  for  the  signs  and 
symptoms of hypocalcemia after major head and neck surgery. In the special instance of the 
gastric pull-up patient, calcium requirements and the range of serum calcium fluctuation are 
greatly  increased  compared  to  patients  undergoing  more  traditional  methods  of 
reconstruction.
Kelly A30 et. al. published their review results on outcomes of long-term swallowing TLPO 
with gastric transposition reconstruction. Ten patients underwent clinical examination and 
completed the performance status scale for head and neck questionnaire and also a gastric 
pull-up  swallowing  questionnaire  designed  for  this  review.  Nine  of  the  10  patients 
underwent videofluoroscopic examination of swallowing. One patient had a stricture at the 
orogastric anastomosis, and one patient had bilateral tongue immobility secondary to XIIth 
nerve palsies. Eight participants reported eating a normal diet, and five reported not limiting 
their eating environment. Regurgitation, slower eating and reduced capacity were the most 
common functional  limitations.  They concluded that gastric pull-up procedure has good 
swallowing outcomes, and indicate that such outcomes continue in the long term.
Shenoy31  et al analyzed the mortality and morbidity following TLPO with pharyngogastric 
anastamosis  done as  a  single-stage procedure.  The technique employed was esophageal 
extraction by stripping method followed by gastric pull up. In 104 patients transportation of 
the stomach was done through posterior mediastinum and in one patient through presternal 
route.  Significant  post-operative complications included pharyngocutaneous fistula in 15 
patients (14.3%) and pneumonitis in 20 patients (19%), fifteen patients (14.3%) died due to 
the causes related to surgery. All patients who survived were able to swallow solid and 
liquid food, on an average of 14 days post-operatively. They concluded that the stomach as 
a conduit following TLPO is a procedure which has given satisfying results when done in 
carefully selected patients.
Al  Ghamdi  SA32 et  al  published  their  study  on  Pharyngolaryngo-esophagectomy  with 
immediate gastric pull-up.  Fifteen patients with carcinoma of the hypopharynx and cervical 
esophagus underwent TLPO with immediate gastric pull-up procedures over a period of 
nine years at the Asir Central Hospital in the southwestern region of Saudi Arabia. The 
most common complication was cervical fistula, which with its sequelae occurred in 40%. 
Postoperative function in terms of swallowing ability was good but rehabilitation of speech 
was poor. The overall hospital mortality was 7%, and the crude survival rate was 40%. The 
most common cause of long-term failure was the recurrence of the disease. They concluded 
that the success of this operative procedure depends on wide surgical excision of cancer 
along with rapid reconstruction of alimentary canal.
Schilling  MK et  al33 analyzed  results  of  long-term  survival  of  patients  with  stage  IV 
hypopharyngeal  cancer:  impact  of  fundus  rotation  gastroplasty.   They  have  included 
patients admitted with circular hypopharyngeal cancer and extension to the esophagus were 
enrolled  in  a  multidisciplinary  treatment  protocol,  including  circular 
laryngopharyngoesophagectomy  with  tracheostomy,  neck  dissection,  and  pull-up  of  a 
fundus  rotation  gastric  tube  that  was  anastomosed  to  the  oropharynx.  Five  weeks 
postoperatively  high-dose  radiotherapy  (60  Gy)  was  given  to  the  cervical  region. 
Altogether, 18 qualifying patients were explored cervically, were found to have resectable 
lesions (i.e., without carotid artery infiltration), and were included in the protocol. After 
laryngopharyngoesophagectomy, an elongated gastric tube was pulled up to the oropharynx. 
The average distance bridged with the tube was 32 +/- 4 cm. No anastomotic leaks were 
found on postoperative Gastrografin swallow, and oral feeding was started between days 5 
and 8. Patients were discharged with normal oral feeding on day 21 (+/- 17 days). Diarrhea, 
postprandial fullness, and reflux resolved within 6 months postoperatively. Five patients 
died during the follow-up period of 42 months (range 3-63 months): three due to cardiac 
events 18 and 38 months postoperatively and two within 12 months with residual disease 
and tumor recurrence, respectively. The estimated 5-year survival was 60%. We concluded 
that an aggressive multidisciplinary approach including TLPO, neck dissection, and high-
dose radiotherapy ascertains good long-term survival and good functional results in patients 
with advanced hypopharyngeal cancer when the intestinal continuity is reconstructed with a 
fundus rotation gastroplasty.
Samir A34 et  al  published results of mortality and morbidity of primary pharyngogastric 
anastomosis following circumferential excision for hypopharyngeal malignancies. Seventy-
five patients underwent  gastric transposition for  replacement  of  the pharyngoesophagus. 
These patients had primary or recurrent malignant tumors of the hypopharynx, postcricoid 
region,  and  cervical  esophagus.  The  operative  procedure  consisted  of  a  transhiatal 
esophagectomy and gastric pull-up to establish gastrointestinal continuity, with a unilateral 
or bilateral neck dissection where indicated. Seven patients died a mortality rate of 9.33%. 
The average hospital stay of uncomplicated cases was 18 days and for complicated cases 
was 40 days. Immediate restoration of oral intake was achieved in 70.6% of patients. They 
conclude that  gastric  transposition  after  circumferential  laryngopharyngeal  excision  is  a 
procedure with low mortality and acceptable morbidity leading to early relief of dysphagia.
S.  B.  Dudhat35 et  al analyzed Complications  following  gastric  transposition  after  total 
laryngo-pharyngectomy.  A retrospective analysis of 60 patients undergoing total laryngo-
pharyngectomy  with  gastric  transposition  was  performed  between  June  1991  and  June 
1996.  The  analysis  focused  on  morbidity,  mortality  and  long-term  function  following 
gastric  transposition.  The  post-operative  mortality  was  8.3%  and  the  peri-operative 
morbidity  31.2%.  The  average  hospital  stay  was  15  days.  Immediate  restoration  of 
swallowing was achieved in 83% of patients. They concluded gastric transposition after 
total laryngo-pharyngectomy is a safe procedure and can be performed with low mortality, 
acceptable morbidity and good long-term function.
Z. Ferahkose36 et al published their results on comparison of free jejunal graft with gastric 
pull-up  reconstruction  after  resection  of  hypopharyngeal  and  cervical  esophageal 
carcinoma.   They  evaluated the operative outcomes of a gastric pull-up and free jejunal 
graft reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. 
Records  of  all  patients  who  underwent  esophageal  resection  for  carcinoma  of  the 
hypopharynx and cervical esophagus were reviewed. Reconstruction after esophagectomy 
was performed using the gastric pull-up (n = 38) or free jejunal graft (n = 14) techniques. 
The hypopharynx was the most common primary tumor site for the free jejunal graft group, 
whereas the gastric pull-up group had lesions more frequently in the cervical esophagus 
(P < 0.05).  Both  operative  time  and  blood  loss  in  the  gastric  pull-up  group  were 
significantly longer and excessive than those of the free jejunal graft group (P < 0.05). The 
graft survival rate was 95% (32/34) in the gastric pull-up group and 93% (13/14) for the 
free jejunal transfer group. The overall leakage rate was 1.9% (1/52). Three patients died 
(6%)  in  the  postoperative  period.  There  was  no  significant  difference  with  regard  to 
operative morbidity and mortality between the gastric pull-up group and free jejunal graft 
group. They concluded, both free jejunal graft and gastric pull-up are safe and effective 
methods for the immediate restoration of alimentary continuity.
Jean-Pierre  Triboulet56 et  al  published  results  of  Surgical  Management  of 
Carcinoma of the Hypopharynx and Cervical Esophagus a analysis of 209 Cases. 
They reviewed the records of patients who underwent total pharyngolaryngectomy between 
May 1982 and July 1999. The majority of patients had advanced cancer: hypopharyngeal in 
131 cases and cervical esophageal in 78 cases.  The postoperative in-hospital mortality 
rate  was  4.8%  (10  patients),  with  a  postoperative  morbidity  rate  of  38.3%. 
Alimentary  continuity  was  achieved  using  the  stomach (127  patients),  colon  (5 
patients),  or  free jejunal  autograft  (77 patients).  The 1-year  and 5-year survival 
rates were 62% and 24%, respectively. There was no significant difference with 
regard to the survival between gastric transposition and free jejunal autograft, but 
there were fewer complications in the gastric pull-up group (33% Vs 47%, P_.05). 
The significant adverse factors affecting survival were tumor cervical localization, 
postoperative  complications,  disease  stages  pT3  and  pT4  for  the  cervical 
esophageal tumors, microscopic pharyngeal penetration, or incomplete resection. 
The  significant  beneficial  factors  were  tumor  hypopharyngeal  localization  and 
postoperative radiotherapy. They concluded that surgical ablation is a viable option 
for  advanced hypopharyngeal  and cervical  esophageal  neoplasm, with stomach 
interposition  the  preferred  method  of  reconstruction.  Although  the  prognosis  is 
poor,  satisfactory short-term palliation can be achieved.  The significant  adverse 
factors affecting survival should be taken into account to select the candidates for 
surgery. 
AIMS AND OBJECTIVES
The  aims  of  this  study  are  to  analyze  following  outcomes  of  patient  with  advanced 
hypopharyngeal cancers treated with Total Laryngopharyngoesophagectomy (TLPO) with 
gastric tube reconstruction. 
1. Surgical outcomes
2. Overall survival
3. Prognostic factors influencing survival
4. Recurrence patterns.
MATERIALS AND METHODOLOGY
The study was conducted in Cancer Institute (WIA), Chennai. Case records of 122 patients 
out of 608 patients with histologically confirmed hypopharyngeal cancer were reviewed 
who underwent TLPO over 6 years period from 2001 to 2006. There were 69 males and 53 
females. TLPO was carried out in 120 patients and total laryngopharyngectomy was done in 
two patients. 101 patients underwent neck dissection along with TLPO and gastric pull up 
was done in 120 patients and free jejunal flap reconstruction was done in one patients. One 
patient underwent total laryngopharyngectomy and control pharyngostoma and 97 patients 
received adjuvant radiotherapy.
All  the patient’s  were ECOG performance status  1.  Patients  underwent through clinical 
examination  including  indirect  laryngoscopy,  direct  laryngoscopy and  biopsy,  and  UGI 
endoscopy if possible, complete haematological examination, X-ray chest, Imaging of neck, 
chest  and  abdomen  as  required  and  histopathological  confirmation  of  malignancy.  All 
patients  underwent  detailed  pre-anaesthetic  check-up  including  cardiac  and  respiratory 
evaluation and optimization for surgery. Patients diagnosed to have carcinoma hypopharynx 
with clinical Stage III and IVA was included for surgery and tumor with circumferential 
involvement of hypopharynx, involvement of postcricoid growth or pyriform sinus growth 
with involvement of apex of pyriform sinus or extension into cervical esophagus were taken 
up for surgery. 
SURGICAL DETAILS
All the patients were admitted before surgery and necessary supportive treatment was given 
before surgery. 
SURGICAL TECHNIQUES
After endotracheal intubation adequate skin preparation was done from the face up to the 
upper  thigh  and  draping  was  done  as  required.  Skin  flaps  were  raised  subplatysmally 
through an apron incision and assessment of tumor resectability and extension was made. 
Neck dissection was done as necessary. Patient with N0 at presentation neck underwent 
bilateral level II to IV nodal dissection and patient with N+ under went either MRND or 
RND and level II to IV nodal clearance in N0 side.  Circumferential mobilisation of the 
hypopharynx was done. Contralateral thyroid lobe was preserved after assessing the tumor 
extension. Pharynx was entered through the vallecula or through the contralateral pharynx 
and circumferentially divided with adequate gross clear margin. Trachea was divided with 
adequate margin.     
Abdomen was opened through a midline upper abdomen incision and esophagus divide at 
esophagogastric junction after excluding any pathology in the stomach. Gastric tube was 
made based on right gastroepiploic vessels with linear cutting GI staplers. Vein stripper was 
introduced through the hypopharynx to esophagus down to abdomen and tied all-around at 
the lower end, stomach tube also connected with a long cotton tape and than stripper gently 
pulled  with  minimum force  from the  neck  and  esophagus  stripped  up-to  the  neck  and 
specimen  retrieved.  Mediastinum is  inspected  for  bleeding.  Stomach  tube  is  pulled  up 
gently through posterior mediastinum without any twist and pharyngogastric end to end 
anastomosis was done in single layer, interrupted, either with 3-0 silk or 3-0 vicryl. Levator 
scapulae muscle flap was used to cover carotid vessels in patient who under went RND or 
MRND. Complete haemostasis was achieved. Chyle leak was checked by applying positive 
pressure  ventilation.  Wound closed  over  two suction  drains  and  tracheostoma matured. 
Feeding  jejunostomy  was  done  for  all  patients.  All  patients  received  broad  spectrum 
antibiotics once at the time of induction of anaesthesia and continued upto 3rd postoperative 
day. Jejunostomy feeding was started on 1st postoperative day and increased gradually. Trial 
oral  feeding was started on 8th postoperative day and was increased gradually based on 
patient tolerance. Radiotherapy was started within four to six weeks of surgery for most of 
the patient. Follow-up was done with history and clinical examination in each visit, X-ray 
chest yearly, Endoscopy as necessary. Frequency of follow-up was every monthly for first 
year, every alternate monthly in 2nd year and 3 monthly in 3rd year and 6 monthly for next 
two years and there after every yearly.
STATISTICAL ANALYSIS
Done by actuarial methods calculated using SPPS software.
Pictures showing Laryngo Pharyngectomy Esophagectomy Specimen
Stomach tube ready for pull-up                     Stomach tube in neck
After Pharyngogastric anastomosis
OBSERVATION AND RESULTS 
Case records of 122 patients were analysed. Follow-up compliance was also ascertained. 
Patient who has not come for regular follow-up health condition were enquired by writing 
letter to their address or by telephone call. Four patients were lost to follow-up immediately 
after completion of treatment and details of their health condition could not be collected. 
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AGE WISE DISTRIBUTION OF PATIENTS
Follow-up periods for remaining patient ranging from 22 months to 72 months and median 
follow-up is 19.5months.
1. Age Distribution
In our series youngest patient was 23 years old and eldest patient was 76 years old. Most of 
the patients were 30 to 60 years of age. Median age is 47 years. Here we analyzed the 
specific subsets of hypopharyngeal cancer who underwent TLPO.
 2.
SEX DISTRIBUTION
69 
(57% )
53 
(43% )
Male Female
Majority of patients are male. Though it  is common in males but recently incidence of 
hypopharyngeal cancer is increasing in females.   
2. Surgical procedures performed:-
     Surgical excision                                                     No of patients
         Total laryngopharyngoesophagectomy (TLPO) –      120
         Total Laryngopharyngectomy                 -                      2
         Neck dissection                                       -                   101
    Reconstruction**
           Gastric Pull – up                                -          120 
      Free jejunal flap reconstruction        -              1
      Controlled pharyngostoma                -             1
** One patient developed intraoperative hypotension after laparotomy and which was not 
improved after adequate support and hence only Total Laryngopharyngectomy and  control 
pharyngostoma and feeding jejunostomy was done and gastric pull up was planned after 
stabilisation.  But  patient  developed  multiple  medical  complications  postoperatively  and 
expired due to septicaemia and multiorgan failure.  
During initial 21 cases, clinical N0 at presentation neck dissection was not considered but 
subsequently all the patient under went neck dissection as required. Subsequent 61 patients 
with N0 at presentation underwent bilateral level II to IV nodal clearance and 40 patients 
N+ at presentation underwent MRND in N1 patients and in N2 patient underwent RND or 
extended RND. In few cases levator scapulae flap was used to cover carotid in the neck to 
prevent carotid blow out if there is salivary leak. 
3. Histopathology         Squamous cell carcinoma – 116
                                           Poorly differentiated carcinoma – 4
                                           Adenoid cystic carcinoma – 2
Table showing Pathological Stage distribution:
Variables No of pts Total
Stage
PII
PIII
PIVA
7
38
77
122
T Status
PT2
PT3
PT4a
12
57
53
122
N Status
PN0
PN1
PN2
Nx (ND not  done)
41
17
43
21
122
116 patients were of Squamous cell carcinoma and 60 patients were node positive 
out of 101 neck dissection patients. 77(63%) patients were of pathological stage 
IVA, 38 patients of  Stage III  and 7 patients of  Stage II.  Pathological  T3 & T4a 
consists of 110 (90%) patients.
5. ADJUVANT RADIATION THERAPY (RT)
97 patient  out  of  122 received adjuvant  radiotherapy.  7  patients  were clinically  though 
advanced stage disease but on pathological staging was of early stage disease and hence 
adjuvant RT was not considered, and few patients because of complications radiotherapy 
could not be started on time and hence post operative RT not received. Most of the patient 
received 50 to 60 Gy RT. 
Total dose of RT  (Gy) No of patient’s
< 50 21
50-60 75
>60 1
Total 97
6.  HOSPITAL SHORT TERM - MORBIDITY AND MORTALITY
POSTOPERATIVE MORTALITY
5 (4.06%)  patients  expired  within  30  days  of  surgery.  One patient  died  of  DIC on 8th 
postoperative day. Three patients expired because of sudden cardiac arrest within 30days of 
surgery  and  one  patient  expired  on  27th postoperative  day  because  of  septicaemia  and 
multiorgan failure.  Out of this 5 patient one patient had stomach tube necrosis.
MORBIDITY
Significant postoperative complications occurred in 40 patients (32.78%).  Twenty-seven 
anastomotic  leaks  (22%)  were  observed,  out  of  which  10  patient  required  surgical 
interventions for fistula closure. 17 patients had minor leak which were completely resolved 
on regular dressing. There were 6 stomach tube necrosis.   This were salvaged by free 
jejunal  flap  reconstruction  in  2,  colonic  pullup  in  one  patient,  Pectoralis  Major 
myocutaneous  flap  (PMMC)  reconstruction  in  4  patients,  by  the  use  of  a 
deltopectoral myocutaneous flap in 1 patient.
Table showing various complications
Variables No of patients %
Salivary leaks
 Major
Minor
27 22.13
10 8.19
17 13.9
Hypocalcemia 10 8.1
Stomach  tube 
necrosis
6 4.9
Chyle leak 2 1.63
Carotid blow out 1 0.8
Wound complications 6 4.9
Pharyngotracheal 
fistula
1 0.8
Septicaemia 3 2.45
Intestinal Obstruction 1 0.8
Pulmonary 
complication
3 2.45
Two patients underwent thoracotomy and ligation of thoracic duct. Three patients 
were on ventilator support for long time for pulmonary complications. Patient who 
developed pharyngocutaneous fistula healed spontaneously following conservative 
management within 2weeks.
Morbidity in neck dissection patients
Neck dissection          Complications
           Present Absent
No  of 
pts No  of 
pts
% P 
value
No  of 
pts
%
Done 101 32 31.68 NS 69 68.31
Not Done 21 8 38.09 13 61.9
Salivary leak according to neck dissection
Neck dissection Salivary Leak
Present absent
No of pts % No  of 
pts
%
Tota
l 
Not done 21 7 33.33 14 66.66
Done 101 20 19.8 81 80.19
Salivary  leak  occurred  in  7(33.33%)  patients  out  of  21  patients  where  neck 
dissection was not considered and 20 (19.8%) patients out of 101 patients who 
underwent  neck dissection.  It  appears from here that  neck dissection does not 
associated with increased in morbidity.
Trial oral feeding was started on 8th postoperative day and depending on tolerance 
gradually increased. Few patient oral feeding was started on 4th postoperative day 
and patient  could tolerate.  The average time of  resumption of  oral  feeding was 
12days and 66% of patient resumed oral feeding within 15 days of surgery.
Once patient could tolerate normal diet they were discharged and were called for 
adjuvant radiotherapy with 1 to 2 weeks gap. The average hospital stay for the 
whole population was 18 days (range 8-45days).
7. OVERALL SURVIVAL AND ONCOLOGICAL RESULTS 
Tumor recurrences occurred in 41 patients (33.6%).  Median time to recurrence 
8months  (Range 1-27months).   Local  recurrence as first  failure occurred in  14 
patients, only regional recurrence occurred in 12 patients and distant recurrence 
occurred  in  9(7.3%)  patients.  Most  of  these  recurrence  cases  presented  in 
advanced disease or poor performance status and hence most of them received on 
symptomatic treatment. 
Disease free survival and overall survival at 3 years was 39% and 43% respectively. The 5 
year over all survival was 34%.
To identify  prognostic  factors,  we  evaluated  the  survival  rates  for  each  of  the 
following parameters,  as  presented in following table.  Only four  of  the possible 
prognostic  factors were found to actually influence survival:  Pathological  Stage, 
Pathological T status and postoperative complications, post operative radiotherapy 
(P=0.008) in univariate analysis. In the subset of
of patients with bilateral selective lateral neck dissection PN0 versus PN2 5 year over all 
survival  (51.4% Vs 21.6%)  stastically  significant(P-0.03).  In  multivariate  analysis  only 
pathological Stage was found to be prognostic factor for survival. 
Overall Survival: Prognostic Parameters Issued From the Univariate Analysis
Variables No of pts Recurrence 5 year over all survival
Stage
PII
PIII
PIVA
7
38
77
% P value
1
9
32
14.2
23.7
41.6
64.29
50.98
23.36
.0505
2Vs4
 0.04
T Status
PT2
PT3
PT4a
12
57
53
3
17
22
25
29.8
41.5
45.88
44.37
22.03
.0996
3Vs4
.046
N Status
PN0
PN1
PN2
41
17
43
10
5
16
24.4
28.5
29.4
53.0
46.7
37.8
NS
Nx  (ND  not 
done)
21 11 52.4 20.5
Post OP RT
Yes
No
97
25
38
42
39.2
16
35
31
.0081
Morbidity
Yes
No
40
82
18
23
45
28
26
39
.0060
Sex
Male
Female
69
53
29
13
42
24.5
25
48
.57
Table showing Survival pattern according to neck dissection
Neck 
dissection
No of 
pts Recurrence
Regional 
recurrence
No of pts % No of pts %
5  years 
OS %
P value
A* 21 11 52.38 6 28.57 33.3
B* 61 17 27.86 5 8.19 37.7
C* 40 13 32.5 6 15 33.3
0.50
*  A  –  Neck  dissection  not  done,  B  –  Bilateral  lateral  selective  neck  dissection,  C  – 
Therapeutic neck dissection
Table showing results of bilateral lateral selective neck dissection. 
Path
N 
status
No  of
Patients %
Recurrence Regional 
recurrence
No % No %
5  year 
OS % 
P value
PN0 28 45.9 7 25 2 7.14 51.4
PN1 11 18 3 27.27 1 9.09 33.06 at 
4 years 
PN2 22 36.1 7 31.81 2 9.09 21.6
0.10 NS
PN0 Vs PN2 
= .03
Total 61 17 27.86 5 8.19
Total 61 patients N0 at presentation underwent bilateral level II to IV nodal dissection and 
out of which 33(27%) patients found to have occult nodal metastasis which is similar to 
various study11.   Out of 61 patient 17 patients developed recurrence, and among these 5 
(8.19) patients in develop nodal recurrence, 2(7.14%) patients in PN0, 1(9.09%) patient in 
PN1 and 2(9.09%) patients in PN2 recurred in neck. Survival PN0 versus PN2 is stastically 
significant (P- 0.03). In PN1 group non of the patient completed 5 years follow-up till the 
study period and hence 4 years overall survival is considered.
1. OVERALL SURVIVAL CURVE
Overall survival
OS duration in months
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                                                5 year over all survival 34%
2. SURVIVAL ACCORDING TO PATHOLOGICAL STAGE
3. SURVIVAL ACCORDING TO PATHOLOGICAL T STATUS
Overall survival difference was not significant according to pathological T status, but there 
was definite statistical significance of survival difference between PT3 Vs PT4a 
Survival Function
Duration in months
706050403020100-10
C
u
m
 S
u
rv
iv
a
l
1.2
1.0
.8
.6
.4
.2
0.0
Pathological Stage
IVA
III
II 
Overall Survival
Duration in months
706050403020100-10
C
um
 S
ur
vi
va
l
1.2
1.0
.8
.6
.4
.2
0.0
Pathological T 
  4a
  3
  2
3. SURVIVAL ACCORDING TO PATHOLOGICAL N TATUS
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DISCUSSION
Management of carcinoma of the hypopharynx is a challenge to the head and neck surgeon 
(50, 51). Various techniques have been utilized to effect pharyngeal continuity with each with 
varying morbidity and mortality 52. The optimal reconstructive procedure should provide the 
lowest  mortality  and morbidity,  the shortest  hospital  stay,  and the most  rapid return to 
successful feeding  (53,  54). At present, no general criteria exists as to which methods is the 
perfect reconstruction method after TLPO. Over the last 40 years, the use of stomach as a 
method of reconstruction has become one of the most popular method of reconstruction 49.
MORTALITY:
Several series have reported mortality rates ranging from 5% to 55% [2, 45, 38, 47,]. In the study 
by Shenoy RK31 et al  30 days postoperative mortality was 14.3% and in S. B. Dudhat35  et al 
series postoperative mortality was 8.3% and in the study by  Jean-Pierre Triboulet56 30 
days postoperative mortality rate was 4.8% and in  our study 30 days postoperative 
mortality was 4.06% which is similar.
MORBIDITY: 
In choosing the reconstructive method,  post  operative complications are  very important 
factor. Several series have reported acceptable morbidity ranging from 5 to 31%[2,45,38, 47,] . In 
the present study morbidity was 32.78 which is comparable to other studies. 
SALIVARY LEAK:
Among the complications majority was salivary leak ranging form 7% to 37% leakage rates 
reported  in  various  study  [2,  45-47].  The  incidence  of  clinically  evident  anastomotic 
leakage has decreased in the last 5 years to 10.5% for Bardini55 et al and to 4.5% 
as quoted by Lam et al45. In the study by Shenoy RK31 et al following TLPO 15 (14.3%) 
patients  out  of  104  patients  developed  anastomotic  leak.  In  the  study  by  Jean-Pierre 
Triboulet56 et  al  forty-seven out of  209 patients had anastomotic  leaks (22.5%), 
including  11  patients  that  were  clinically  evident  and  36  patients  were 
asymptomatic  but  detected  radiologically,  and  that  closed  without  surgical 
correction. Where free jejunal grafts had been used, the fistulas always occurred 
proximally. In the present study 27 (22%) patients out 122 patients developed anastomotic 
leak and among which 10 (8%) required surgical intervention which is similar to above 
study. Stomach tube was necrosed in 5 patients out of 127 gastric tube transpositions in the 
above mentioned study by Triboulet56 et al and in our study 6 patients had stomach tube 
necrosis out of 122 patients which is similar.   
PULMONARY COMPLICATION:
Pulmonary complication following TLPO reaches upto 20% in various studies [57.58],  In the 
study by Shenoy RK31   et al 20(19%) patients developed pneumonitis following TLPO. In 
our  study  only  3  (2.45%)  patients  had  severe  pulmonary  complication  which  required 
ventilator support for a long time postoperatively and improved subsequently. In the study 
by Jean-Pierre Triboulet56  four patient died because of pulmonary infections. But in our 
study there was no death because of pulmonary complication.
HYPOCALCEMIA:
Another common complication following TPLO is hypocalcemia. In the study by  Krespi 
YP29 et al following TLPO 73% of their patients developed hypocalcaemia. Management of 
these patients required a combination of oral and intravenous calcium supplement and many 
patient  required  vitamin  D  supplementation  as  well.  In  our  study  10  (8%)  patients 
developed  severe  hypocalcemia  and  which  required  intravenous  calcium  injection  in 
immediate postoperative period and subsequently improved on oral calcium and Vitamin D 
supplement.
INFECTIOUS COMPLICATIONS: 
 Wound infection  developed in  6  (4.9%)  of  our  patients  which  is  lower  than  previous 
reported study by J. Rezaie1 58 which is 10%.
Carotid blow out one of the rare life threatening emergency complication which may occur 
following  laryngopharyngeal  resection  if  associated  with  neck  dissection.  One  of  our 
patients who had salivary leak developed carotid artery blow out on 7th postoperative day 
for which emergency carotid artery was ligated to save the patient and following that there 
was  no  neurological  deficit  and  subsequently  patient  underwent  jejunal  free  flap 
reconstruction for fistula closure.
Chyle leak one of the complication following neck dissection most of the time in the left 
side and most of the times leak stops on conservative management. Two of our patients 
developed  chylothorax  and  persisted  despite  of  intercostals  drainage(ICD)  and   hence 
underwent thoracotomy and ligation of the thoracic duct on 8th and 14th postoperative day.  
RESUMPTION OF ORAL FEEDING
The major goal of the TLPO is early resumption of the oral feeding. Most of the patients 
present with varying forms of dysphagia.  In the study by  Jean-Pierre Triboulet56 et al 
the average time of resumption of feeding was 19.7 days following the operation 
(range, 0-700 days). Excluding the postoperative deaths, swallowing was achieved 
in 98.4% of patients. Only 3 patients were not able to swallow after recovering from 
the procedure: 2 because of necrosis of the jejunal graft and 1 because of a major 
swallowing disorder. In our study 66% of patient resumed oral feeding within 15 
(range  4-90days)  days  of  surgery  and  excluding  the  postoperative  deaths 
swallowing was achieved in all patients. 
AVERAGE HOSPITAL STAY
In the study by Jean-Pierre Triboulet56 et al the average hospital stay for the whole 
population was 23.6 days (range, 1-240 days). In our study average hospital stay 
was 18 days (range 8-45days) which is similar.
RECURRENCE
In the study by  Jean-Pierre Triboulet56  tumor recurrences occurred in 118 patients 
(59.3%), with a mean delay of 19 months (range, 1-104 months).
These patients were treated by chemotherapy,  radiotherapy,  or neck dissection. 
Local  recurrence  alone  occurred  in  46  patients  and  was  combined  with  neck 
recurrence in 48 patients.  Distant  metastases were found in 22 patients,  and 2 
patients had tumor recurrences at unknown sites. In our study 41 (33.6%) patients 
developed recurrence and median time to recurrence was 8 months (range 1-27 
months).   Most  of  the  patients  presented  with  advanced  disease  or  with  poor 
performance  status  and  hence  most  of  them  were  treated  with  symptomatic 
treatment  only.  Local  recurrence  as  first  failure  occurred  in  14  patients,  only 
regional  recurrence  occurred in  12  patients  and  distant  recurrence  occurred in 
9(7.3%) patients.
OVERALL SURVIVAL:
The  overall  5-year  survival  rates  for  advanced  Squamous  cell  carcinomas  of  the 
hypopharynx  has  not  changed  significantly,  despite  advances  in  surgical  techniques, 
chemotherapy,  and  radiation  therapy.  Actuarial  5-year  survival  rates  reported  in  the 
literature range from 18% to 35% regardless of therapy (2, 38-44). In the study by Jean-Pierre 
Triboulet56 5  year  overall  survival  was  29%.  and  in  our  series,  the  overall  5-year 
survival rate  was 34% which is similar the various study.
CONCLUSION
           Surgical resection followed by adjuvant radiotherapy remains the standard of 
treatment for advanced hypopharyngeal carcinoma and gastric interposition is the 
preferred  method  of  reconstruction  for  circumferential  defect.  In  our  study  the 
mortality  and  morbidity  rates  were  comparable  with  other  studies.  Prophylactic 
bilateral level II to IV nodal clearance should be considered for patients with N0 at 
presentation as there were no increase in morbidity by doing neck dissection and 
there was high percentage of occult nodal metastases in our study and specifically, 
the difference in long term survival is  statistically significant  among PN0 versus 
PN2 (P=0.03)  in  this  subset  of  patient,  where  we  can consider  modification  in 
adjuvant therapy. Overall survival in our study is comparable with other studies. In 
our study prognostic factors which influenced overall  survival were: Pathological 
Stage (Stage II  Vs Stage IVA, P=0.04), pathological T status (PT3 versus PT4, 
P=0.046),  postoperative  complications  (P=0.0060)  and  adjuvant  radiotherapy 
(P=0.008).  Organ  preservation  strategies  have  not  been  as  successful  in 
hypopharyngeal  cancers  as  for  cancers  of  other  head  and  neck  sites.  Further 
studies  will  be  necessary  to  compare  the  use  of  chemoradiotherapy,  larynx 
preservation, and surgery in terms of overall survival and quality of life, especially 
the ability to continue oral feeding.
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